Precision Oncology: Biomarkers, Multi-Omics, AI
Received Date: Jul 01, 2025 / Accepted Date: Jul 29, 2025 / Published Date: Jul 29, 2025
Abstract
Precision oncology is rapidly evolving, driven by innovations in biomarkers and technologies. Circulating tumor DNA and liquid biopsies offer non-invasive detection and monitoring. Advanced sequencing, spatial multi-omics, and single-cell analysis provide deep insights into tumor biology. Key biomarkers like Tumor Mutational Burden and Immunoscore guide immunotherapy. Metabolomics complements genomic studies, while Artificial Intelligence integrates diverse data for personalized treatment. These advancements collectively enhance diagnosis, prognosis, and therapeutic strategies, shaping the future of cancer care.
Citation: Laurent B (2025) Precision Oncology: Biomarkers, Multi-Omics, AI. jcd 09: 308.
Copyright: 漏 2025 Beatrice Laurent This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted聽use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 419
- [From(publication date): 0-0 - Apr 08, 2026]
- Breakdown by view type
- HTML page views: 350
- PDF downloads: 69
